[Methodologic problems in studying cardiologic drugs].

N A Mazur

PubMed · 3533619

[Methodologic problems in studying cardiologic drugs].

Abstract

Methodological difficulties arising on studying clinical efficacy of novel antiarrhythmic and antianginal drugs are discussed. Combined data on the evaluation of the action of the drugs are presented. The comparison of the results obtained in an acute drug test and during course treatment indicates the agreement of the data on efficacy of the absolute majority of antianginal and antiarrhythmic drugs. The interaction of propranolol and nifedipine was taken as an example to show that despite an opposite character of the pharmacodynamic action potentiation of the effect is observed. The author believes that the final determination of the drug value can be given only following the assessment of its effect on long-term outcomes.

Explore related subjects

Cardiovascular Agents Clinical Trials as Topic Electrocardiography Humans Placebos Clinical Trial Comparative Study English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

N A Mazur. [Methodologic problems in studying cardiologic drugs].. https://pubmed.ncbi.nlm.nih.gov/3533619/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

[Diastolic dysfunction of the left ventricle as a cause of heart failure: a clinical problem].

Explore the source record for details and available documents.

Cardiovascular Agents↗

PubMed1995

Nursing management of congestive heart failure. Part I.

Congestive heart failure (CHF) is a common clinical problem and in its advanced stage has a poor prognosis. Approximately 400,000 individuals develop heart failure each year (Parmley 1989). CHF can be caused by coronary artery disease such as myocardial infarction, ischemia and hypertension. Should heart failure occur as a result of acute myocardial infarction, a classification tool developed by Killip can be used to assess the degree of CHF. Killip's classification is organised into the following four categories: Class I: no heart failure Class II: mild to moderate failure Class III: acute pulmonary oedema Class IV: cardiogenic shock (Killip, as cited by Benz 1989). This system helps in organising clinical signs and symptoms of heart failure. Due to the fact that CHF is now the most common hospital discharge diagnosis for those over the age of 65, critical care nurses need to be able to recognise complications and intervene rapidly (Parmley 1989) in collaboration with medical staff. The purpose of this paper is first to discuss cardinal signs and symptoms and clinical data associated with CHF. Second, critical care nurses' management of CHF is organised around common nursing diagnoses.

Cardiovascular Agents↗

PubMed1995

Pharmacologic management of congestive heart failure.

This article is a review of the pharmacologic management of congestive heart failure (CHF) and a summary of the medical literature that guides current treatment strategies. Despite advances in the treatment of CHF, it remains a common diagnosis with a poor prognosis. Because CHF is a progressive syndrome with heterogeneous features of cardiac dysfunction, effective management requires combination therapies and evolving treatment strategies. The mechanism of action, goals of therapy, and demonstrated efficacy of each of the various agents used in the treatment of CHF are discussed.

Cardiovascular Agents↗